Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Investor-rights law firm Bronstein, Gewirtz & Grossman announced that a class action lawsuit has been filed against Regeneron Pharmaceuticals (REGN) and certain officers. The filing itself is not quantified, but it introduces potential legal overhang and liability risk that could weigh modestly on sentiment.